Pure Global
NCT04198584

Study of Telemedicine Stress Management and Lifestyle Group Intervention for HCV Patients

Pilot Feasibility Testing of a Small Randomized Controlled Trial to Evaluate a Telemedicine Stress Management and Lifestyle Group Intervention for Patients With Symptomatic Chronic Hepatitis C
University of North Carolina, Chapel Hill·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chronic Hepatitis C
Drug/Device/Intervention
VC-CBCS
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of North Carolina, Chapel Hill
Location
Chapel Hill, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 10, 2020
End date
Feb 24, 2021
Enrollment
32 participants
Primary outcome

Percentage of Patients Consented Versus Approached,Percentage of Participants Consented Versus Randomized,Percentage of Standard of Care Condition Participants Retained vs Enrolled,Percentage of VC-CBCS Intervention Condition Participants Retained vs Enrolled,Percentage of Surveys Completed by Participants Who Completed the Study,Global Health Status Physical Health Mean T-Score,Global Health Status Mental Health Mean T-Score,Depression Mean T-score,Anger Mean T-score,Anxiety Mean T-score,Fatigue Mean T-score,Sleep Disturbance Mean T-score,Pain Interference Mean T-score

Summary

A pilot feasibility study of a small randomized controlled trial (RCT) comparing a
 video-conferencing cognitive behavioral coping skills (VC-CBCS) group to standard of care
 (SC) for symptomatic patients previously diagnosed with chronic hepatitis C to evaluate
 feasibility, patient satisfaction and differences in symptoms, quality of life and liver
 markers.

ICD-10 classifications
Chronic viral hepatitis CAcute hepatitis CChronic viral hepatitisOther chronic viral hepatitisChronic hepatitis, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04198584
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04198584 through Pure Global AI's free database. This phase not specified trial is sponsored by University of North Carolina, Chapel Hill and is currently Completed. The study focuses on Chronic Hepatitis C. Target enrollment is 32 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.